Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment
Y Qiu, N Wang, T Guo, S Liu, X Tang, Z Zhong… - Biomaterials …, 2021 - pubs.rsc.org
Hepatocellular carcinoma (HCC), as a well-vascularized tumor, has attracted increasing
attention in antiangiogenic therapies. Notably, emerging studies reveal that the long-term …
attention in antiangiogenic therapies. Notably, emerging studies reveal that the long-term …
[PDF][PDF] Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment
Y Qiu, N Wang, T Guo, S Liu, X Tang, Z Zhong, Q Chen… - researchgate.net
Hepatocellular carcinoma (HCC), which accounts for 85–90% of primary liver cancers, is the
fourth most frequent cause of cancer-associated mortality globally. 1 HCC is known as an …
fourth most frequent cause of cancer-associated mortality globally. 1 HCC is known as an …
Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment.
Y Qiu, N Wang, T Guo, S Liu, X Tang, Z Zhong… - Biomaterials …, 2021 - europepmc.org
Hepatocellular carcinoma (HCC), as a well-vascularized tumor, has attracted increasing
attention in antiangiogenic therapies. Notably, emerging studies reveal that the long-term …
attention in antiangiogenic therapies. Notably, emerging studies reveal that the long-term …
Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment
Y Qiu, N Wang, T Guo, S Liu, X Tang… - Biomaterials …, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), as a well-vascularized tumor, has attracted increasing
attention in antiangiogenic therapies. Notably, emerging studies reveal that the long-term …
attention in antiangiogenic therapies. Notably, emerging studies reveal that the long-term …